Research programme: monoclonal antibody BC1 - Antisoma

Drug Profile

Research programme: monoclonal antibody BC1 - Antisoma

Alternative Names: HuBC-1; huMabBC1; Humanised monoclonal antibody BC1; Monoclonal antibody BC-1

Latest Information Update: 07 Aug 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Istituto Nazionale per la Ricerca Sul Cancro
  • Class Monoclonal antibodies
  • Mechanism of Action Angiogenesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Solid tumours

Most Recent Events

  • 07 Aug 2006 Discontinued - Preclinical for Solid tumours in United Kingdom (Parenteral)
  • 30 Jun 2002 Preclinical trials in Solid tumours in United Kingdom (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top